Chungnam National University Hospital
Daejeon, South Korea
NCT Number: NCT06767553
Despite technological advancements in living donor liver transplantation (LDLT), biliary complications (BC), including biliary anastomotic stricture (BAS) and bile leak (BL), remain unresolved issues that significantly affect patient outcomes. Biliary stenting has emerged as a potential method for reducing BC in LDLT procedures; however, their necessity remains debated. This study aimed to assess the necessity of biliary stenting by retrospectively comparing the bile duct complication rates in LDLT using duct-to-duct anastomosis with or without biliary stenting.
This study is active but is not currently recruiting participants.
Notify Me19 year–80 year
All sexes
Observational
Daejeon, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within 10 years after liver transplantation
The primary outcome measure is the incidence of biliary complications, including bile leaks and biliary anastomotic strictures, within 10 years post-liver transplantation. Measurment is done by electronic medical record review of post-operative imaging and clinical diagnosis during follow up period.
Chungnam National University Hospital
Other
Impact of Non-stenting Method with Mucosal Eversion on Biliary Complications Post-LDLT in a Mid-volume Center: a Propensity Score-Matching Analysis of Case-Control Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06865612
Digestive System Diseases, Hepatic Insufficiency
Daejeon, South Korea
View Trial DetailsNCT05234190
Behavior, Digestive System Diseases
Brussels, Belgium
View Trial DetailsNCT02991105
Cancer, Cardiovascular Diseases
Birmingham, West Midlands, United Kingdom
View Trial DetailsNCT01366144
Adnexal Diseases, Breast Carcinoma
Duarte, California, United States
View Trial Details